Lv1
40 积分 2024-05-21 加入
Combination therapies: the next major frontier in IBD management
2天前
已完结
Blimp-1 Is Required for the Formation of Immunoglobulin Secreting Plasma Cells and Pre-Plasma Memory B Cells
18天前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
24天前
已完结
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
29天前
已完结
Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
29天前
已完结
Design of amidobenzimidazole STING receptor agonists with systemic activity
30天前
已完结
Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint
30天前
已完结
Repression of c-mycTranscription by Blimp-1, an Inducer of Terminal B Cell Differentiation
1个月前
已完结
BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells
1个月前
已完结
Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects
1个月前
已完结
皖公网安备34019202002308
